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Abstract  
Tremendous research and commercialization efforts around the world are focused on developing 
novel wearable electrochemical biosensors that can noninvasively and continuously screen for 
biochemical markers in body fluids for the prognosis, diagnosis and management of diseases, as 
well as the monitoring of fitness. Researchers in North America are leading the development of 
innovative wearable platforms that can comfortably comply to the human body and efficiently 
sample fluids such as sweat, interstitial fluids, tear and saliva for the electrochemical detection of 
biomarkers through various sensing approaches such as potentiometric ion selective electrodes 
and amperometric enzymatic sensors. We start this review with a historical timeline overviewing 
the major milestones in the development of wearable electrochemical sensors by North American 
institutions. We then describe how such research efforts have led to pioneering developments 
and are driving the advancement and commercialization of wearable electrochemical sensors: 
from minimally invasive continuous glucose monitors for chronic disease management to non-
invasive sweat electrolyte sensors for dehydration monitoring in fitness applications. While 
many countries across the globe have contributed significantly to this rapidly emerging field, 
their contributions are beyond the scope of this review. Furthermore, we share our perspective on 
the promising future of wearable electrochemical sensors in applications spanning from remote 
and personalized healthcare to wellness. 
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1. Introduction  
Wearable sensors are integrated with the human body to help monitor remotely and continuously 
the wearer’s health and performance. While wearable sensors enabling physiological data 
collection have widely been applied in medical and consumer products, their potential role in 
managing the current COVID-19 pandemic has gained tremendous recent attention  (Adans-
Dester et al., 2020). With many studies supporting the relevance of COVID-19 to multiple 
physiologic metrics, such as resting heart rate, respiration rate, blood oxygen saturation, core and 
skin temperature, wearable sensors could also aid early detection of presymptomatic viral 
infections/transmissions and thus, allowing timely interventions to prevent imminent outbreaks  
(Seshadri et al., 2020). Besides the commercially available wearable sensors and activity 
monitors (Apple Watch, Fitbit, or WHOOP Strap) that track vital signs and physical metrics, the 
new generation of wearable chemical and biochemical sensors can offer a comprehensive 
molecular information toward diverse applications in major fields, ranging from personalized 
medicine, athletes or soldier performance, nutrition and wellness, safety and security (Yang and 
Gao, 2019). Such wearable biosensors enable noninvasive measurements of the dynamically 
fluctuating biochemical markers in peripheral biofluids, such as sweat, interstitial fluid (ISF), 
tears, and saliva (Kim et al., 2019; Yang and Gao, 2019).  
While the rapid recent progress in the field of wearable chemical sensors has been made through 
major contributions from many influential researchers from across the globe, this review focuses 
exclusively on the developments of wearable chemical sensors in the North American region. In 
particular, the United States (US) has played a pivotal role in the majority of the cutting-edge 
wearable chemical sensor research, with pioneering contributions from several leading groups. 
Figure 1 presents the current main academic players in the area of wearable biosensors within 
North America. Unfortunately, our analysis did not identify major active research groups 
focusing on wearable chemical sensors in Canada and Mexico, although we noticed several new 
Canadian start-ups which are active in this area. Thanks to major investments and highly skilled 
human capital, the US is known as home for many technological innovations, with its Silicon 
Valley serving as the worldwide technology center and home to giant high-tech corporations, 
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such as Apple, Intel, or Google. Coupling such a dynamic private sector with leading universities 
attracting many creative talents, and major US government funding (from agencies such as DOD 
and NIH), has made this country the leading force in technological areas, such as the Internet of 
Things (IoT) or digital medicine. In addition, owing to rapidly growing healthcare demands, the 
US has led the development of commercial continuous glucose monitoring (CGM) systems that 
have inspired the introduction of wearable chemical sensors for other target analytes.  
When the first wearable CGM device was introduced by Minimed iPro in the late 1990s, many 
people doubted its ability to replace the self-monitoring blood glucose (SMBG) strips (Garg and 
Kaan Akturk, 2018). Later in 2005, Medtronic (USA) commercialized the first CGM device 
(marketed as Guardian TM), and this was followed in 2006 by the STS system from Dexcom 
(USA). Major improvements in the design, functionality, and cost of CGM devices over the past 
decade have now made CGM devices the new standard of care for many patients with diabetes 
(Teymourian et al., 2020a). By offering remote monitoring of diabetic patients, such wearable 
CGMs have recently played a pivotal role during the current coronavirus pandemic, 
circumventing major risks of blood testing by healthcare providers.  
Early efforts toward wearable non-invasive sensor technology have faced some skepticism 
regarding their ability to offer reliable monitoring of chemical markers. This may in part be due 
to the challenges experienced by the first commercial real-time, non-invasive CGM, the 
GlucoWatch (Cygnus Inc., CA). This first non-invasive glucose sensor platform received FDA 
approval in 1999 but was later retracted from the market due to reported skin irritations and 
reproducibility issues (Kim et al., 2018a). Nevertheless, the pioneering idea of wristwatch-based 
chemical monitoring has inspired researchers to pursue innovative ideas toward the development 
of a wide range of powerful wearable chemical sensing platforms. Yet, expanding the 
commercial success of market driven CGM to other clinically important analytes, and to 
different biofluids has experienced key challenges. However, due to innovative technological 
and scientific advances in diverse areas, ranging from nano/micro-fabrication methods, materials 
chemistry, flexible electronics, to bioelectronics, along with the advent of digital communication 
technology and wireless sensor networks, the field of wearable chemical sensors has experienced 
a major boom over the past decade (Choi et al., 2019; Kim et al., 2019; Yu et al., 2020b).  
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In this review article, we will provide a historical overview of substantial achievements in the 
field of wearable platforms made in North America over the past decade, starting from the early 
stage (2008-2014), followed by the middle stage (2015-2017) and ending with the present state-
of-the-art (2018-2020). We will also discuss the prospects and challenges for the next decade 
(2020-2030) in order to stimulate further activity and advances in this paradigm-shifting 
technology. Subsequently, we will highlight different wearable platforms along with various 
electrochemical and recognition approaches utilized in wearable systems. This section will be 
followed by a discussion of the sampling methods available to access different biofluids. We will 
conclude with a brief overview of ongoing commercialization efforts, while staying 
geographically focused on North America throughout this article. 
2. Historical perspective of wearable electrochemical sensors 
Figure 2 shows a timeline depicting key advances in wearable chemical sensors by North 
American researchers over the past two decades, starting with the introduction of the first 
commercial CGM devices including GlucoWatch (Fig. 2a) and Medtronic’s Minimed (Fig. 2b) 
in early 2000s. In this section, we review the evolution timeline of these landmark developments 
in the wearable chemical sensors field.  
The early stage (2008-2014) 
During the early stage, the first devices with potential wearability were described by combining 
traditional sensing chemistries and versatile electrode fabrication techniques involving flexible 
body-compliant substrates. These early studies laid the foundation for the current on-body 
wearable platforms. A pioneering report in 2008 described a miniaturized flexible thick-film 
rolled glucose biosensor, suitable for insertion into the tear drainage canal, fabricated by screen 
printing onto a polyimide substrate (Kagie et al., 2008). In a follow up study in 2010, the same 
group challenged a flexible biosensor printed on the PET substrate against severe bending-
induced mechanical stress and demonstrated that such a platform can tolerate repeated bending 
cycles (Chuang et al., 2010b). In the same year, we witnessed the first textile-based wearable 
sensor realized through screen printing on the elastic waist of underwear (Fig. 2c) (Yang et al., 
2010). Such textile sensors with the electrodes in direct contact with the skin displayed an 
attractive electrochemical performance toward in-vitro detection of chemical markers. This study 
was followed by another report on textile sensors in 2010, describing the same principle but with 
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the electrodes printed on the outside surface of garments toward detection of explosive threats 
present in the surrounding environment (Chuang et al., 2010a). The next year, 2011, we saw the 
first report on a  contact lens with embedded sensor for potential application in tear glucose 
monitoring (Fig. 2d) (Yao et al., 2011). In the same year, the use of microneedle arrays toward 
minimally invasive detection of biomarkers on the tip of microneedles was reported (Fig. 2e) 
(Windmiller et al., 2011). In 2012, the first salivary sensor was reported, relying on the printing 
of graphene on bioresorbable silk that was transferred onto a tooth enamel to warn against 
bacteria in saliva, while also achieving wireless powering and readout (Fig. 2f) (Mannoor et al., 
2012). Epidermal sensors based on transfer tattoos were introduced by Wang’s group in 2012 
(Fig. 2g and 2h) (Windmiller et al., 2012). The same group described the first glove-based 
sensor for voltammetric detection of security threats (Bandodkar et al., 2013b). Finally in 2014, a 
wearable mouthguard biosensor was developed by Wang’s group for amperometric lactate 
biosensing in human saliva samples (Fig. 2i)  (Valdés-Ramírez et al., 2014a). 
The rapid growth stage (2015-2017) 
During this medium stage, major advances were made for translating the early wearable designs 
closer to their ultimate aim of on-body application. The first reports of fully-integrated wearable 
sensors toward wireless transmission of sensed information to the user interface were published 
in 2015, based on radio frequency identification (RFID) adhesive patch for hydration monitoring 
in sweat (Fig. 2j) (Rose et al., 2015) and on Bluetooth low energy (BLE) transceiver integrated 
with a mouthguard platform for salivary uric acid monitoring (Kim et al., 2015b). In a landmark 
development, in 2016,  Javey’s group in UC Berkeley demonstrated the first example of a fully-
integrated, multiplexed wearable sensor which could be integrated in a wristband or a headband 
enabling the detection of a number of metabolites and electrolytes in sweat samples (Fig. 2k) 
(Gao et al., 2016a). During the same year (2016), Rogers’ group integrated a soft, flexible and 
stretchable microfluidic system into a multiplexed sweat patch sensor powered by wireless 
electronics, enabling spontaneous sweat routing into the fluidic network and a set of reservoirs 
towards simultaneous colorimetric detection of pH, chloride, glucose and lactate (Koh et al., 
2016). The sweat fluidic sampling principle was further expanded by Wang’s group in 2017 
towards  the integration of the electrochemical biosensors inside the reservoir of microfluidic 
device (Martín et al., 2017). While sweat sampling in these studies were based on fitness cycling, 
two different studies in 2016 and 2017 (Fig. 2l) demonstrated iontophoretic-based sweat 
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stimulation to sample the biofluid under sedentary condition (Emaminejad et al., 2017; Kim et 
al., 2016). Another key advance was the introduction of a hybrid chemical-electrophysiological 
sensor that offered simultaneous monitoring of both biochemical and electric signals toward 
attaining more comprehensive information on health status of individuals (Imani et al., 2016). 
With growing needs for on-body security monitoring applications, year 2017 witnessed the 
development of wearable sensors for defense and safety (Fig. 2m and 2n), including ring- and 
glove-based sensors for detecting vapor explosives and nerve-agents for the safety of wearers 
and first responders (Mishra et al., 2017; Sempionatto et al., 2017a). 
The present state-of-the-art (2018-2020) 
Over the past three years, the major research activity and trends in wearable chemical sensors 
research have focused on expanding the scope of detectable analytes, from the common 
metabolites or electrolytes to more challenging biomarkers, and toward improving of the design 
and fabrication of the wearable systems. In this regard, an innovated design for sweat stimulation 
based alcohol monitoring was reported in 2018, relying on the use of ‘hex-wick’ material to 
reduce the required sweat sampling volume and hence, to reduce the sweat-blood lag time (Fig. 
2o) (Hauke et al., 2018). A report in 2019 described mass fabrication of microfluidic sensing 
patches via roll-to-roll processes for reproducible sweat analysis (Fig. 2p) (Nyein et al., 2019). 
Innovative fabrication was also demonstrated in the integration of an epidermal microfluidic 
BFC sweat biosensor with colorimetric sensors (Fig. 2q) (Bandodkar et al., 2019). Continued 
fabrication innovations in 2020 involved the large scale fabrication of laser-engraved graphene-
based wearable sweat sensors for low concentration analytes including uric acid and tyrosine 
(Fig. 2r) (Yang et al., 2020). Another 2020 report illustrated a freestanding sensor system-
enabled smartwatch featuring sweat sampling, electrochemical sensing, and data 
display/transmission in sedentary and high-intensity exercise settings (Fig. 2s) (Zhao et al., 
2020). Major advances have also been achieved toward self-powered wearable devices including 
the first demonstration of a complementary metal-oxide-semiconductor (CMOS) biofuel cell 
(BFC)-based low power chemical biosensor with digital wireless readout (Yeknami et al., 2018), 
, a solar cell-powered fully-integrated smartwatch for sweat glucose monitoring (Zhao et al., 
2019), and a flexible, fully sweat-powered integrated electronic skin toward multiplexed 
metabolic sensing (Fig. 2t) (Yu et al., 2020a). Efforts aimed at expanding the scope of detectable 
analytes beyond common metabolites and electrolytes, have led to  the detection of stress 
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hormone cortisol in sweat relying on various recognition elements of bioaffinity-based 
(Torrente-Rodríguez et al., 2020a) and molecularly imprinted polymer (MIP)-based (Parlak et 
al., 2018) sensors. Additionally, several studies have reported the detection of various drugs, 
either therapeutic or illicit, in sweat and ISF samples (Goud et al., 2019; Mishra et al., 2020a; Tai 
et al., 2019, 2018; Yang et al., 2020). Add to these, the studies on utilizing the great potential of 
electrochemical aptamer-based sensors toward in-vivo detection of drug targets in blood samples 
of anesthetized animals (Arroyo-Currás et al., 2018; Dauphin-Ducharme et al., 2019). Although 
the catheter-based blood monitoring used in such aptamer-based sensors was invasive, such 
bioelectronic detection route holds considerable promise in real-time, continuous minimally 
invasive or non-invasive monitoring of a wide range of endogenous and exogeneous target 
analytes, including drugs, proteins and hormones.  
The transitional stage into commercial devices (2020-2030) 
With the continuing advances and innovations from North America and around the globe during 
the next decade, we expect to see rapid translation of the technology into the medical devices 
toward health monitoring in real-life applications. Such transitional step should involve 
improving the sensor characteristics toward addressing key challenges faced with real scenarios 
of on-body monitoring (e.g., biofouling) along with the extensive preclinical and clinical trials, 
and validation of the data against gold standard measuring techniques to ascertain the required 
standard level of precision and accuracy. 
While the field of diabetes care remains to be the major focus, seeking for innovations mainly 
toward developing miniaturized CGM wearables with longer life span, self-powered and 
multiplexed sensing ability, major efforts will be directed to translate the wearable chemical 
sensing technology to other important fields with huge potential markets. Therapeutic drug 
monitoring (TDM) using wearables has already attracted lots of interest (Teymourian et al., 
2020c), owing to the aging population and the high prevalence of drugs, and we expect to see 
first commercial TDM wearables during the forecast period. Fitness monitoring, personalized 
nutrition, and security monitoring are other fields expected to take some share in the growing 
market of wearable chemical sensors. The current coronavirus pandemic has further ignited the 
interests in remote monitoring capability for the people who are in need of receiving constant 
medical care. The next wave of wearable sensors is anticipated to expand the application areas of 
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wearable devices from healthcare to sports, law enforcement, defense, security and even to space 
missions.  
With most of the current activity inside the US is taking place in a few leading universities from 
west coast area, we anticipate increasing contributions from institutions in the Midwest and east 
coast. Also, growing contributions from our Canadian and Mexican neighbors will be foreseen 
during the present decade.  
3. Wearable platforms 
Epidermal sensors 
Unlike traditional rigid and freestanding electrochemical sensors, skin-interfaced epidermal 
electrochemical sensors need to comply with the soft and curvilinear surface of the human skin. 
Thus, epidermal sensors are engineered to be flexible or stretchable, while retaining desirable 
electrochemical and mechanical stabilities. Furthermore, for commercialization and widespread 
use of epidermal electrochemical sensors, production costs must be reduced through low-cost 
and scalable mass manufacturing procedures (Matzeu et al., 2020). To meet such requirements, it 
is necessary to meticulously choose substrate materials, electrode materials, and electrode 
fabrication techniques. Researchers in North America have explored various scalable fabrication 
procedures such as screen printing, gravure printing, inkjet printing, and laser engraving to 
pattern electrochemical electrodes on substrates such as plastics, textiles, and paper for the 
development of epidermal electrochemical sensors. 
Screen printing is a standard sensor fabrication technique widely adopted in point of care blood 
glucose sensor strips. Silver/silver chloride and carbon electrodes have been screen printed on 
temporary transfer tattoo paper to form flexible and highly conformal tattoo biosensors (Fig. 3a) 
for the real time analysis of sweat biomarkers such as pH and lactate (Bandodkar et al., 2013a; 
Jia et al., 2013). In addition, stress-enduring inks have been engineered to screen print a biofuel 
cell-supercapacitor system on a textile to demonstrate energy harvesting from sweat and energy 
storage during exercise (Fig. 3b) (Lv et al., 2018). A similar printing approach can be adopted 
for textile-based self-powered sweat sensors (Jeerapan et al., 2016). On another account, roll-to-
roll gravure printing was used to mass produce electrochemical electrodes on a 150 m flexible 
PET roll, and the resulting sensors were used to monitor sweat pH during exercise (Bariya et al., 
2018). An attractive alternative to printing electrodes is to laser engrave graphene electrodes on 
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PI substrates using a CO2 laser-cutting machine. A single laser-cutting machine was used to 
fabricate all key components of a disposable epidermal microfluidic sensor patch, including 
highly sensitive laser engraved electrochemical and physical sensors as well as a microfluidic 
module (Fig. 3c) (Yang et al., 2020).  
Bandage based epidermal sensors have also been developed for the monitoring of key 
biomarkers in open wounds such as pH and uric acid (Kassal et al., 2015). Screen printing was 
used to directly screen print electrodes on the cellulose pad of commercial bandages; Stencil 
printing was used to print electrodes on a layer of omniphobic paper that is sandwiched between 
the bandage and an absorbent pad (Fig. 3d) (Guinovart et al., 2014; Pal et al., 2018).  
Sweat sensing platforms 
For wearable use, epidermal electrochemical sweat sensors are integrated into a wearable 
platform that can comfortably adhere to the skin while acquiring and distributing real-time 
electrochemical sensor data. Advances in wearable sweat sensing platforms are driven by 
miniaturization of sensors, advances in material science, power and size reduction of flexible 
electronics, and innovations in energy harvesting. Researchers in North America have 
implemented batteries and various energy harvesting approaches in powering wearable 
electronics to acquire frequent electrochemical measurement data and conveniently transmit the 
data to a smart phone via Bluetooth, high-frequency passive RFID, and NFC protocols. When 
determining an appropriate power source and data transmission technology for the platform, it is 
crucial to consider factors such as the sweat sensor’s intended application, electrochemical 
measurement technique, and location of wear.  
The first demonstration of a fully integrated multiplexed wearable sweat sensing platform 
consisted of an absorbent pad interfaced flexible sensor array, a Bluetooth enabled wireless 
FPCB, and a lithium battery all fixed into place by a transparent wristband or headband (Fig. 3e) 
(Gao et al., 2016a). Sweat-sensing smart watches with integrated display modules have also been 
demonstrated (Zhao et al., 2019, 2020). In one account, the sweat-sensing smart watch integrates 
a flexible solar cell and a flexible rechargeable battery as a watch band to self-power the 
platform.  
If paired with low-powered electronics and adequate power management strategies, wearable 
energy harvesting modules such as solar cells, biofuel cells, and triboelectric nanogenerators can 
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steadily scavenge ambient energies to continuously power battery-free wearable sweat sensing 
platforms. A flexible and fully perspiration-powered integrated electronic skin platform 
demonstrates that highly efficient lactate biofuel cells can scavenge energy from our sweat 
metabolites power the continuous data acquisition and Bluetooth transmission of multiplexed 
sweat sensors without a battery (Fig. 3f) (Yu et al., 2020a). A flexible PCB based triboelectric 
nanogenerator was also integrated in a battery-free wearable platform to harvest energy from 
exercise induced human motion for the dynamic monitoring of sweat electrolytes (Song et al., 
2020). Factors such as the availability of light, sweat, and body motion may steer the usage of 
these battery-free sweat sensing platforms toward different application scenarios.  
Passive RFID and NFC based battery free wearable electrochemical sweat sensors can harvest 
radio frequency energy to acquire and transmit measurement data to a mobile phone over a short 
distance. An adhesive RFID sensor bandage with minimal electronic components was developed 
for the potentiometric measurement of sweat electrolytes (Fig. 3g) (Rose et al., 2014). In passive 
RFID or NFC enabled sensors, an electrochemical measurement can be performed every instance 
the phone is brought near the antenna. While a potentiometric electrolyte measurement can occur 
nearly instantaneously, many sweat metabolite sensors are based on chronoamperometric and 
voltammetric measurements that need to actively bias the sensors for at least tens of seconds. 
Therefore, short distance radio frequency energy harvesting devices are generally desirable for 
passive and instantaneous electrochemical measurements such as potentiometry, or in scenarios 
where the user can bring the smart phone into proximity of the wearable device for some 
duration. A hybrid skin patch that implements the colorimetric analysis of sweat electrolytes and 
the electrochemical analysis of sweat metabolites tackles this limitation of NFC-based devices by 
using BFCs as sensors (Fig. 3h) (Bandodkar et al., 2019). Instead of using the glucose or lactate 
BFC to power the electronics, the BFC generated voltage signal indicates the sweat metabolite 
concentration that can be instantaneously acquired at an NFC activation event. 
Tear sensing platforms  
Tears composition includes a variety of medical relevant biomarkers such as glucose, uric acid 
and different electrolytes. Yet, when compared with other noninvasive biofluids (e.g., saliva, 
sweat), tear is a relatively simple biofluid having less proteins in its composition due to the 
blood-tear barrier filtering process that decreases the tear protein content. This feature is 
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attractive for continuous monitoring of analytes, using wearable platforms, as the low protein 
density minimizes their nonspecific adsorption and, therefore, the surface biofouling. Hence, a 
variety of wearable tear biosensing platforms has been developed over the past decade by North 
America researchers.  
The Google contact lens, developed in collaboration with Parviz’s lab, is a great example of the 
efforts toward wearable tear sensors (Senior, 2014; Yao et al., 2012, 2011). It involved 
integration of an amperometric glucose sensor and wireless electronics on a contact lens for 
continuous glucose monitoring (Fig. 3i). Powering these devices constitutes a major challenge. 
Thus, additional efforts were directed toward the integration of an energy harvesting biofuel cell 
onto the contact lenses for a battery-free self-sustainable contact lens biosensor (Reid et al., 
2015).  
Alternative platforms based on fluidic devices were also introduced for the “on the flow” 
detection of tears analytes, increasing further the operational time of the sensor by minimizing 
the contact of the sensor with the biofluid. A small rolled flexible thick-film electrochemical 
biosensor was presented for monitoring dynamic changes in norepinephrine and glucose levels in 
tears (Kagie et al., 2008). This involved screen-printing of an enzyme modified ink on a flexible 
Kapton substrate which was laterally rolled to create the fluidic channel for insertion in the tear 
canal (Fig. 3j). A less invasive approach, with no contact with the eyes, was presented by 
combining a fluidic sensor with an eyeglass for the monitoring of several tears’ analytes 
(Sempionatto et al., 2019a). A super hydrophilic fluidic channel was integrated on the nose pad 
of the eyeglasses for simultaneous tears collection and analysis (Fig. 3k). The system was 
applied successfully for electrochemical monitoring of tears glucose, vitamins and alcohol. Such 
eyeglass platform offers integration with smart glasses devices and incorporation of the 
electronics and batteries onto the eyeglasses’ frame.   
Choosing an appropriate platform for tears analysis is crucial for the successful application of the 
wearable sensor. Continuous or time discrete analyses demand different platforms and are related 
to different types of analytes and tears (e.g. basal or reflex). Several reviews have discussed the 
criterion for the selection as well the advantage and disadvantages of each platform (Kim et al., 
2019; Tseng et al., 2018; Yu et al., 2019).  
Saliva sensing platforms  
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Saliva is an easily accessible non-invasive biofluid which is rich in chemical information. 
Accordingly, wearable salivary sensors have been extensively studied. However, prolonged 
operation of such oral salivary wearables is subject to major challenges involving:  i) keeping a 
foreign device in the mouth over extended period; ii) toxicity and biocompatibility issues; iii) 
risk of contamination from food or bleeding gums; iv) surface biofouling from salivary 
macromolecules.   
Despite these challenges, researchers in North America have demonstrated salivary sensing in 
dental accessories (Mannoor et al., 2012), mouthguards (Kim et al., 2015b; Valdés-Ramírez et 
al., 2014b), and even in foodstuff (García-Carmona et al., 2019). Mouthguards are oral devices, 
commonly used for protection against sports-related dental injuries, are convenient platforms for 
the short-term monitoring of activity associated biomarkers such as lactate and electrolytes 
(Valdés-Ramírez et al., 2014b). A lactate mouthguard sensor was developed by integrating 
flexible screen-printed lactate-oxidase modified electrodes and wireless electronics into the 
mouthguard structure (Fig. 3l). The same concept of a mouthguard metabolite biosensor was 
demonstrated for the amperometric monitoring of uric acid for monitoring the treatment efficacy 
of gout disease (Kim et al., 2015b). For other circumstances, implantable tooth and dental 
adhesives have been demonstrated (Mannoor et al., 2012).  
Salivary sensors are especially important for the safe development of wearables for babies. Most 
of the existing wearables for infants are bulky, rigid and cannot perform biochemical detection. 
A pacifier-based biosensor for the monitoring of saliva glucose in infants was recently developed 
(García-Carmona et al., 2019). A regular pacifier with a modified nipple fluidic system was thus 
used for simultaneous saliva collection and detection (Fig. 3m). The pacifier fluidic sensor uses 
the natural mouth movement of the baby for pumping saliva through the fluidic channel towards 
the biosensor detection chamber located outside the mouth.  
Wearable saliva biosensors can be readily expanded towards the monitoring of several other 
clinically relevant biomarkers, offering useful and timely insights into the adult and babies’ 
health. 
Accessories sensing platforms 
As the wearable sensor technology evolved rapidly in North America, reliable and low-cost 
sensors are on the verge of commercialization by several successful startups. Instead of 
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introducing additional sensor-carrying wearable platform, such commercial efforts would benefit 
from adding the sensing functionality directly onto existing devices or accessories. The use of 
common accessories, such as contact lens (Yao et al., 2011), eyeglasses (Sempionatto et al., 
2019a), gloves (Barfidokht et al., 2019), pacifiers (García-Carmona et al., 2019), and watches 
(Zhao et al., 2020), has been largely explored in parallel with textile-based sensors for functional 
sensing and/or energy harvesting. 
New platforms and applications have been recently explored by North American researchers 
toward the development of wearable chemical sensors. A versatile ring sensor platform has been 
demonstrated for safety and security applications involving rapid detection of vapors of 
explosives and nerve agents (Sempionatto et al., 2017a). For this, a screen-printed solid 
electrolyte sensor was designed to fit in the cap of a 3D printed ring case, where the customized 
miniatured electronics was enclosed (Fig. 3n). A similar ring-based platform was used for on-
site detection saliva THC and alcohol (Mishra et al., 2020b). Variety of other devices contacting 
our body are expected to integrate sensing or energy harvesting capabilities.   
ISF sensing platform 
The interstitial fluid (ISF) is extremely attractive for biomedical applications of wearable 
devices, since its composition is closely related to the blood (Heikenfeld et al., 2019). ISF is the 
fluid surrounding the cells and it is in constant equilibrium with blood capillaries through 
diffusion. There are basically two approaches to access this biofluid: a) Reverse iontophoresis 
(RI) or b) epidermal microneedles devices.  
RI consists in applying a mild electric current through the skin using two electrodes, the cathode 
and the anode. The current then induces ions to migration from the inside of the skin to the 
surface carrying small non charged molecules, such as glucose, within the electro-osmotic flow. 
A tattoo-like epidermal sensor, coupling RI extraction and amperometric detection, was used 
successfully for tracking ISF glucose levels (Bandodkar et al., 2015). In addition, RI ISF 
extraction was combined with direct iontophoretic sweat stimulation for the simultaneous 
monitoring of glucose in ISF and alcohol in sweat (Kim et al., 2018b). Microneedle sensing 
devices, used to puncture the outer skin layer to access ISF with no pain or damage, providing an 
attractive minimally invasive wearable platform for monitoring ISF biomarkers with the 
possibility of integrating different sensors on a single microneedle array. Hollow microneedles 
J
urn
al 
Pr
e-p
roo
f
 14
were used for electrochemical detection of alcohol (Mohan et al., 2017), L-dopa (Goud et al., 
2019), tyrosinase (Ciui et al., 2018) and as self-powered glucose sensors (Valdés-Ramírez et al., 
2014c) (Fig. 3o). 
Owing to the significant medical relevance, ISF sensing platforms offer great promise for future 
development of closed loop systems, where the correct concentration of analyte must be detected 
in order to adjust the drug concentration to be delivered. Such ‘Sense-Act’ applications would 
require extremely reliable (accurate and stable) ISF sensors.  
4. Chemical approaches  
North America is well known for the highly developed electronics sector. This fast-evolving 
semiconductor industry has amplified research efforts toward wearable bioelectronic sensors. 
This sensor category relies on the measurement of an electrical signal, originated from the 
interaction of the analyte and a recognition element immobilized on the sensing surface, with the 
signal intensity being proportional to the analyte concentration. The wearable chemical sensing 
area has largely benefited from the advances in electronics where different electrochemical 
approaches have been integrated with miniaturized electronics for fast and autonomous on-body 
operations. There are three operational modes commonly used for wearable bioelectronics: 
amperometry, voltammetry and potentiometry techniques (Fig. 4), although other modes - such 
as impedance or field effect transistors (FET) - have been reported in a few cases. Selecting the 
electrochemical detection technique depends mostly on the target analyte, with potentiometry is 
commonly used for monitoring electrolytes (e.g. Na+ and Cl-) while amperometry is the method 
of choice for detecting key metabolites (e.g. glucose and lactate). An appropriate 
(bio)recognition layer is included in the sensor design to impart the selectivity, based on which 
the wearable sensors are classified into enzyme-, ionophore-, and affinity-based platforms. In 
this section, we briefly discuss the various electrochemical approaches and the recognition 
chemistries used in wearable devices. 
Amperometric sensors 
Amperometric sensors rely on the monitoring of current at a fixed applied potential, with the 
temporal current variations reflect the dynamically-changing analyte concentration (Wang, 2006) 
(Fig. 4a). There are several criteria to be considered when choosing the appropriate electrode 
material, the applied potential, and the surface modification. Most commonly, wearable 
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amperometric biosensors rely on carbon or platinum electrodes modified with redox enzymes. 
Enzymatic sensors offer great selectivity for the target analyte in the complex biofluids (sweat, 
saliva, tears or ISF) due to the selective enzyme recognition. An amperometric dual enzyme 
sensor was developed for the simultaneous monitoring of alcohol in sweat and glucose in ISF 
with great selectivity (Kim et al., 2018b) (Fig. 4ai). In addition, a multiplexed freestanding 
(motion independent) wearable sensor system based on enzyme recognition, mounted on a 
smartwatch, was able to successfully monitor different analytes (lactate, glucose) in sweat during 
physical activity and in the resting state (Zhao et al., 2020) (Fig. 4aii). The oxidase family of 
enzymes has contributed to a considerable number of wearable enzymatic sensors, reported for 
detecting important analytes, such as alcohol (Campbell et al., 2018; Hauke et al., 2018; Kim et 
al., 2016), lactate (Currano et al., 2018; Gao et al., 2016a; Sempionatto et al., 2017b), vitamin C 
(Sempionatto et al., 2020), and glucose (Bandodkar et al., 2015). Such oxidase enzyme-based 
wearable platforms commonly rely on detecting the oxidation of the hydrogen peroxide 
enzymatic product (Fig. 4a). Second generation oxidase biosensors rely on the use of mediators 
as electron acceptors instead of oxygen, in which mediators shuttle electrons from the enzyme to 
the electrode surface, reducing the overpotential and minimizing the redox reaction of 
interferents. Glucose biosensor is one of the most studied systems due to the tremendous interest 
in the management of diabetes (Kim et al., 2018a; Wang, 2008; Zhao et al., 2019). Additionally, 
other enzyme classes have been also reported for wearable sensors, including tyrosinase for 
levodopa (Goud et al., 2019; Tai et al., 2019), 3-hydroxybutyrate dehydrogenase for ketone 
bodies (Teymourian et al., 2020b), and uricase for uric acid monitoring (Kassal et al., 2015; Kim 
et al., 2015b).   
Amperometric wearable biosensors are widely used since they can provide fast and continuous 
response using simple data collection (current monitoring), minimizing the lag time between the 
non-invasive wearable measurements and blood analyte concentration, and offer facile 
integration with low power electric circuits. The main drawback is the limited choice of redox 
enzymes available and hence the limited scope of metabolites that can be easily detected using 
this approach. 
Voltammetric sensors 
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Similar to amperometric sensors, voltammetric sensors rely on measurements of the current 
response but in connection to a potential scanning operation. Such an operation leads to an 
electrochemical (current vs potential) signature, known as a voltammogram, consisting of one or 
more peak currents (Fig. 4b). Depending on the specific applied potential-time waveform, there 
are several voltammetric techniques, including cyclic voltammetry (CV), differential pulse 
voltammetry (DPV), and square wave voltammetry (SWV). A comprehensive discussion on 
these different voltammetric techniques  is presented in the literature (Wang, 2006). 
Voltammetry can offer high sensitivity down to the 10 nM level. Further improvements in the 
sensitivity are achieved by coupling it with a preconcentration step, as in anodic stripping 
voltammetry (ASV) used for detecting trace metals (Gao et al., 2016b; Kim et al., 2015a). For 
wearable sensing voltammetric applications, SWV is commonly used as it couples fast response 
with high sensitivity. DPV also offers high sensitivity. Wearable DPV-based non-enzymatic 
sensors were described for the sweat monitoring of methylxanthine drugs (such as caffeine) (Fig. 
4bi) (Tai et al., 2018) and analgesic drugs (acetaminophen) (Lin et al., 2020). Further, a forensic 
glove  was developed for SWV detection of the opioid drug fentanyl (Barfidokht et al., 2019) 
(Fig. 4bii). Voltammetric techniques have also been demonstrated for the sensitive detection of 
opioids and nerve agents (Mishra et al., 2020a), and explosives (Sempionatto et al., 2017a). 
While offering additional information regarding the redox behavior of the target, voltammetric 
techniques generally have slower response times compared to amperometric detection.   
Potentiometric sensors 
Potentiometric sensors rely on the concentration-dependent potential difference across a selective 
membrane to generate an analytically useful potential difference between the reference and 
working electrodes, in which the latter is referred to as the ion selective electrode (ISE). 
Specifically, the potential difference between the membrane and the reference electrode is 
proportional to the logarithm of the ion activity. The specificity of ISEs relies on the use of 
ionophore receptors, mainly in connection to a polyvinyl chloride (PVC) polymeric membrane 
(Wang, 2006). The pH sensor is a well-known example of potentiometric sensors and it has been 
translated to a variety of wearable platforms, such as epidermal tattoo (Bandodkar et al., 2013a) 
and bandage for wound healing (Guinovart et al., 2014). A wearable platform for pH and Ca2+ 
based on PANI and PEDOT:PSS polymer deposition, respectively, was developed for measuring 
these parameters in body fluids such as sweat, urine, and tears (Nyein et al., 2016). The sensor 
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was validated using inductively coupled plasma-mass spectrometry (ICP/MS) and a commercial 
pH meter toward the diagnosis of primary hyperparathyroidism and kidney stones (Fig. 4ci).  
Solid contact ISE-based wearable sensor has also been developed for monitoring electrolytes 
such as Na+ (Sonner et al., 2017). An iontophoretic sensor was developed for continuous sweat 
generation (over five hours) and sodium monitoring (Fig. 4cii). Solid contact potentiometric 
sensors can readily be used for the continuous, real-time tracking of the electrolytes. They are 
low cost, and highly selective and can simply be integrated with low power consumption 
electronics (Wang et al., 2018). However, potentiometric sensors have intrinsic low sensitivity 
and may be subject to drifts or interferences from other ions competing for the receptor 
recognition.  
Energy harvester sensors 
The major drawback of wearable electrochemical sensors is the need for constant power supply. 
Current batteries are rigid, bulky and not anatomically compliant to the body which hinders the 
performance of the electrochemical wearable sensors (Chen et al., 2020, 2016; Kumar et al., 
2017; Liu et al., 2017; Yin et al., 2018; Zhang et al., 2020). In order to address this challenge, 
flexible and stretchable wearable energy harvesters have been developed to collect usable energy 
present in biofluids to either power the electrochemical sensors or to act as a self-powered 
electrochemical sensor themselves. The mechanism for harvesting energy is similar to the 
conventional fuel cells which employs a pair of anode and cathode electrodes. For wearable 
biofuel cells (BFC), the anode is usually functionalized with enzymes for the electro oxidation of 
the biofuels present in the target biofluid, which generates electrons that flow toward the cathode 
to the oxidant molecule (oxygen), generating a net electrical current that can be used in an 
external circuit (Fig. 4d). The cathode compartment can be modified either with non-biological 
materials such Ru, Pd and Pt, or by utilizing laccase or bilirubin oxidase enzymes for the 
reduction of oxygen present in the biofluid. Efficient BFC have been reported with the use of 
lactate oxidase and bilirubin oxidase for the oxidation of sweat lactate and reduction of oxygen, 
respectively (Chen et al., 2019). An absolute power of 450 µW was achieved when the device 
was applied to the arm of a volunteer during exercise (Fig. 4di) and when connected to a voltage 
booster, this power was enough to power an LED under both pulse discharge and continuous 
discharge modes. A BFC system was integrated in a microfluidic device system for sampling 
sweat during exercising (Bandodkar et al., 2019). The BFC was able to successfully harvest 
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energy from lactate and glucose fuels (Fig. 4dii). Harvesting energy from biofluids is not trivial, 
as our body retains the maximum energy possible, excreting only few molecules with some 
energetic value. To this, hybrid devices combining energy harvesting and storage were 
demonstrated (Lv et al., 2018). The textile-based hybrid device was functionalized in the internal 
and external surfaces. The surface in contact with the body was used for harvesting energy from 
sweat which was stored in the supercapacitors located in the external face. The BFC could also 
act as a self-powered sensor by providing the power source and sensor signal simultaneously, 
with the power output proportional to the fuel/analyte concentration.   
Affinity sensors 
The vast majority of reported wearable platforms have been developed for monitoring common 
metabolites (e.g. glucose and lactate) or electrolytes (e.g. Na+ and Cl-), reflecting the availability 
and easy adaptation of corresponding enzyme- or ionophore-based recognition elements, 
respectively, for continuous on-body operation. While these bioassays are reversible and can be 
used for the continuous operation of wearable devices, their corresponding bioaffinity assays are 
commonly not reversible and hence not reusable. Antibodies are natural biorecognition elements 
which have been well established for in-vitro biosensing applications due to their high specificity 
and large commercial availability for a broad range of target analytes. Antibody-based sensors or 
‘immunosensors’ rely on the specific binding of antibody-antigen with high affinity, typically in 
the nanomolar or picomolar concentration range, to produce a measurable analytical signal (Fig. 
4e). Enzyme labeling immunoassay strategies, either in sandwich or competitive format, have 
been the most widely used immunosensing protocols in portable point-of-care devices. While 
such labeling strategy was recently integrated with on-body platforms toward measuring sweat 
cortisol levels (Torrente-Rodríguez et al., 2020a) (Fig. 4ei), the methodology itself cannot be 
applied for continuous, real-time analyte monitoring due to the inherent problems of antibodies 
as bioaffinity tools such as slow recognition, limited stability, difficult regeneration and their 
need for additional washing or detection steps (Tu et al., 2020). Label-free, non-faradaic 
impedimetric analyses are wash-free and do not require additional reagents and hence, offer 
more feasibility for implementing on-body measurements although still facing the challenge of 
regenerating the free antibody (Kinnamon et al., 2017). Hence, the potential of such devices for 
continuous wearable protein biomarker monitoring applications remains unclear.  
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The limitations of antibody-based natural receptors have stimulated interest in employing 
synthetic receptors with higher stability, cost-effectiveness and scalability. Molecularly-
imprinted polymers (MIPs) have been investigated as potential candidates to natural antibodies. 
MIP-based sensors rely on creating molecular imprinted cavities which are complementary in 
size, shape and chemical functionality with the imprinted (template) molecule (Fig. 4f). 
Regarding the wearable electrochemical monitoring applications, the integration of an MIP 
membrane and organic field effect transistor-based transduction was described for sweat cortisol 
measurement (Parlak et al., 2018) (Fig. 4fi). MIPs can also be paired with voltammetric 
techniques to add an additional layer of selectivity for the sensitive voltammetric detection of 
electroactive molecules. Future development of MIP-based wearable sensors should address the 
problems related to their limited sensitivity (especially for large analytes) and to on-body 
receptor regeneration.  
Aptamers are another class of artificial receptors which have recently shown immense potential 
in continuous, in-vivo monitoring of target analytes. Aptamers functionalized by a redox reporter 
molecule (e.g. methylene blue) can specifically and reversibly bind to the analyte of interest, 
leading to a conformational change (folding) and electrical signal (Arroyo-Currás et al., 2020) 
(Fig. 4g). Such a binding-induced response reflects changes of electron transfer characteristics of 
the redox reporter associated with such folding and is proportional to concentration of the target 
biomarker. The reversible binding nature of the target molecules thus offers great promise for 
real-time, continuous operation in connection to rapid SWV transduction (Arroyo-Currás et al., 
2018). Aptamers can also offer high sensitivities owing to their small size and thus, the 
capability to be packed densely on the sensor surface (Tu et al., 2020). In this sense, 
ultrasensitive (pM) detection of cytokine biomarkers (e.g. tumor necrosis factor-α (TNF-α)) was 
demonstrated using aptamer functionalized graphene channels of a FET device on a flexible 
substrate (Hao et al., 2018) (Fig. 4gi). The limited commercial availability of the aptamer probes 
is the main disadvantage of aptamer sensors as there are only a few aptamer screening companies 
(Arroyo-Currás et al., 2020).  
5. Fluid sampling 
Biofluid extraction is a critical component of non-invasive wearable biomarker sensing (Choi et 
al., 2018). While fluids such as sweat and tears are secreted naturally, medical applications of 
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biofluid monitoring often require on demand and controlled stimulation of adequate sample 
volumes. Also, the extracted biofluid must be collected efficiently and sampled in real-time to 
minimize sample contamination, degradation, leakage and evaporation. Lastly, the physical 
dimensions and characteristics of the extraction and collection segments must be compatible to 
enable smooth and facile integration into a wearable device.  
Sweat stimulation and collection 
Sweat can be stimulated both physically through heat and chemically through drugs. In early 
endeavors, sweat was typically induced physically by controlling environmental temperatures, or 
by generating internal heat through exercise. While exercise induced sweat is a great candidate 
for fitness monitoring, health monitoring and disease diagnostic applications require sweat 
stimulation in sedentary scenarios as well. Fortunately, sweat can also be chemically stimulated 
through iontophoresis, a well-established stimulation method where cholinergic agonists such as 
pilocarpine and acetylcholine are delivered to sweat glands by an electrical current. 
Traditionally, sweat was collected by using whole body washdown techniques, absorbent pads, 
or arm bags for subsequent benchtop analysis (Baker et al., 2009; van Heyningen and Weiner, 
1952).  
The opportunity of sweat based non-invasive diagnosis of cystic fibrosis (CF) in infants spurred 
the development of commercial Macroduct Sweat Collection Systems that include a pilocarpine 
iontophoresis stimulation module, and a fluidic sweat collector wristband module (Hammond et 
al., 1994). While the system’s simplicity and improved sweat collection capacity in terms of 
sample preservation and sample volume was a breakthrough, the system still required three 
rather bulky and separate components for sweat stimulation, sweat collection, and sweat 
analysis. For more convenient and accurate iontophoretic sweat analysis, researchers developed 
miniaturized iontophoretic interfaces and integrated them into wireless wearable sweat sensing 
platforms to stimulate sweat secretion and measure sweat analytes in real time and in situ. 
Iontophoresis electrodes and electrochemical sensors were integrated into a flexible wristband, 
where the chemically induced sweat is collected by a rayon absorbent pad for the immediate 
analysis of sweat analytes such as sodium, chloride and glucose (Emaminejad et al., 2017) (Fig. 
5a). Iontophoresis electrodes and an amperometric ethanol sensor were also integrated on a 
screen-printed wearable tattoo platform for non-invasive alcohol monitoring (Kim et al., 2016). 
Jo
rna
l P
re-
pro
of
 21
Epidermal microfluidic devices can enhance sweat collection by minimizing sample leakage, 
evaporation and contamination, while improving sample transport for better temporal resolution 
and accuracy in sweat analyte measurements. A flexible epidermal microfluidic device 
consisting of a top PDMS sensor layer, a middle PDMS microfluidic layer, and a bottom double-
sided adhesive inlet layer was constructed with the aid of theoretical simulations for the 
optimization of the sampling process (Martín et al., 2017) (Fig. 5 b). Mounted conformally on 
the epidermis, the microfluidic sensor patch was paired with flexible wireless electronics to 
analyze exercise induced sweat glucose and lactate levels. A family of soft, skin-compatible 
microfluidic devices for the colorimetric sensing of sweat have been developed (Choi et al., 
2017; Koh et al., 2016). In one of the examples, an epidermal microfluidic network was 
developed with capillary bursting valves to guide sweat into sequentially filling a series of 
micro-reservoirs for the time dependent chrono-sampling of sweat (Choi et al., 2017) (Fig. 5c). 
While colorimetric sweat sensing is beyond the scope of this review, the microfluidic device 
concepts incorporated in these devices may be adopted for electrochemical sensors. 
In some cases, prolonged iontophoretic stimulation or natural sweat may yield ultra-low sample 
volumes in the nanoliter level. Such low sample volumes would take long to fill microfluidic 
reservoirs and analyte exchange with transport medium such as absorbent pads would foul the 
sample. To overcome these challenges, open nanofluidic polymer wicking films (hex wick) 
coated with gold were developed for the rapid collection and transport of ultra-low sample 
volumes (Twine et al., 2018) (Fig. 5d). A wearable device integrating this hex wick with an 
iontophoresis module, an amperometric ethanol sensor, and a waste pump was developed to 
measure continuous and blood-correlated sweat ethanol levels (Hauke et al., 2018).   
ISF extraction 
While ISF contains a wide array of significant biomarkers well correlated with blood 
concentrations, a lack of effective sampling methods has hindered its use in clinical applications. 
Although ISF is not secreted through skin naturally, reverse iontophoresis and microneedles can 
be used to access the fluids while causing minimal discomfort. Reverse iontophoresis is a variant 
of direct iontophoresis where the current flowing from the anode to the cathode is primarily 
driven by the migration of positively charged sodium ions towards the cathode, rather than by the 
migration of negatively charged drug molecules away from the anode. In reverse iontophoresis, 
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the current increases the permeability of the skin, and the convective flow of cations leads to the 
accumulation of small volumes of ISF at the cathode (Bandodkar et al., 2015). A flexible tattoo-
based wearable platform combining the reverse iontophoretic extraction and amperometric 
detection of interstitial glucose was developed for a proof-of-concept study (Bandodkar et al., 
2015) (Fig. 5e). A mild current was used for ISF extraction and the subjects did not report any 
perceptible discomfort. Taking advantage of the congruence between iontophoretic sweat 
extraction and reverse iontophoretic ISF extraction platforms, a dual-iontophoretic tattoo-based 
biosensor platform capable of simultaneously stimulating sweat (via pilocarpine delivery at the 
anode) and extracting ISF (at the cathode) was developed. The platform was validated through 
the parallel detection of sweat alcohol levels and ISF glucose levels in subjects (Kim et al., 
2018b). 
Microneedles are minimally invasive because they do not penetrate deep enough to reach the 
nerve endings in the dermis. While microneedle patches have been thoroughly investigated for 
epidermal drug delivery, their application for ISF sensing has yet to be explored in depth. One 
approach is to use microneedle patches to extract ISF from the skin (Liu et al., 2020). A 
proteomic study demonstrated that the protein content in microneedle extracted ISF matches that 
in serum and plasma samples in terms of diversity (Tran et al., 2018). To realize real-time and 
wearable electrochemical analysis of microneedle extracted ISF, maximizing sample volume is a 
key challenge. A study conducted to systematically compare the ISF collection efficacies of 
several different types of microneedles, found that porous and hollow microneedles that 
extracted ISF via capillary action could extract more ISF than hydrogel microneedles that relied 
on diffusion (Samant and Prausnitz, 2018) (Fig. 5f). Furthermore, the study found that using 
solid microneedles to puncture micropores in the skin, and subsequently collecting the ISF via 
suction induced negative pressure yields the most sample volume (2.3 ± 2.1 μL per person in 20 
minutes). Applying negative pressure on capillary force driven hollow microneedles is another 
interesting approach to increase ISF flow rate. Integrating these microneedle ISF-sampling 
patches into an epidermal wearable sensor device is a challenge to look forward to in the future.  
Microneedles can also be used for direct ISF analysis based on immobilizing the bioreceptor 
(commonly enzyme) onto electrode transducer present at the microneedle tip (Goud et al., 2019; 
Mohan et al., 2017). Microneedle sensor arrays can be used also for multiplexed electrochemical 
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detection of multiple biomarkers, such as key diabetes biomarkers, in connection to individually 
addressable microneedle electrodes (Teymourian et al., 2020b). 
6. Diabetes-driven commercialization efforts 
While first attempts of glucose quantitation date back to the mid-1800s based on colorimetric, 
semi-quantitative urine glucose measurements, the modern diabetes care started with the advent 
of electrochemical home glucose meters during 1980s. Such self-monitoring blood glucose 
(SMBG) strips have seen many advances over the past 3 decades, with improved accuracy and 
faster response, and have played a pivotal role in daily diabetes management. Major limitations 
of point-of-care SMBG strips, such as the painful finger pricking procedure and limited temporal 
information regarding dynamic glucose fluctuations, have created an enormous desire among the 
diabetes care community for a less painful device that can be worn by the patient and provide 
continuous monitoring of glucose levels (Teymourian et al., 2020a). To realize such a vision, two 
products of Minimed iPro and GlucoWatch Biographer (Cygnus, Redwood, CA) were the first 
platforms appeared in the market. The GlucoWatch was a pioneering device that was approved 
by FDA in 1999 to provide non-invasive ISF glucose readings on a wristwatch. This ambitious 
product failed to live up to the hype and was retracted from the market in 2007. However, the 
introduction of these wearable commercial products sparked an ongoing competition within the 
medical device industry to develop reliable CGM platforms that appeal to the ever-increasing 
diabetes community.  
Major efforts have been directed over the past two decades at overcoming the drawbacks of 
initial CGM products, including limited accuracy and lifetime, need for blood glucose 
calibrations and sensor-pump integration. This activity has led to many breakthrough 
developments into the field, leading to the current generation of CGM platforms as the new 
standard of care for people with diabetes, especially type 1 diabetes patients. The latest versions 
of personal CGMs of Abbott’s FreeStyle Libre 2 (Abbott, Alameda, CA) (“FDA clears Abbott 
Freestyle Libre 2”, 2020) and Dexcom’s G6 (Dexcom, San Diego, CA) (“Dexcom Continuous 
Glucose Monitoring Systems”, 2018) offer calibration-free, continuous glucose monitoring data 
and trends, have alarms to notify the wearer of high (hyperglycemia) and low (hypoglycemia) 
glucose levels and can be worn for up to 14 and 10 days, respectively. As another key 
development, Medtronic (Northridge, CA) gained FDA approval in 2017 for its Guardian Sensor 
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3 with 7 days wear time, which in connection to Medtronic MiniMed 670G insulin pump was the 
first hybrid closed-loop system capable of automatically adjusting basal insulin delivery based on 
glucose readings (“MiniMed 670G Insulin Pump System”, 2017). Such CGM devices, relying on 
a thin needle-mounted enzymatic biocatalytic sensing technology, are now offering competing 
accuracies to SMBG strips, as they have mean absolute relative difference (MARD) of ≤10%.  
With growing accumulative evidence supporting the benefits of CGM devices, such systems 
have gained increasing acceptance and popularity, although immense efforts are currently going 
on to tackle their limited lifetime and high costs, and to provide further miniaturization and 
enhanced data security. Implantable glucose monitoring sensors have also emerged with 
extended wear time. Fluorescence transduction-based Eversense from Senseonics (Germantown, 
MD) has been FDA approved in 2020 with 90 days wear time (Eversense, 2020). Glysens (San 
Diego, CA) is another company working on developing an implantable CGM system, Eclipse 3 
ICGM, which can be potentially worn for up to two years (“Eclipse 3 ICGM System”, 2020). 
Microneedles have also attracted tremendous recent interests. Unlike their needle based CGM 
counterparts which sample the subcutaneous fat tissue at 5-11 mm depth, microneedles reach the 
ISF at ≈500 µm and thus, provide painless glucose monitoring. One promising company, Biolinq 
(San Diego, CA), is currently working on developing such microneedle based CGM patches 
(“Biolinq CGM System”, 2019). Microneedles offer additional advantages of multiplexed 
monitoring of other diabetes biomarkers, along with glucose, toward tighter glycemic control and 
also, the possibility of integrating the sensing and delivery modules on a single patch toward a 
miniaturized fully closed loop patch. 
Developing wearable, non-invasive platforms for glucose measurements constitutes another 
active area of commercialization in diabetes care. For example, researchers in University of 
California San Diego are running clinical trials to evaluate the potential of RI-based tattoo 
sensors for ISF glucose monitoring (Chao et al., 2020). Sweat and tears are other potential 
biofluids which have been investigated for glucose sensing, although a strong correlation 
between the glucose level in these biofluids and blood glucose has not been fully established yet. 
The unsuccessful example of the Google contact lens highlights the extreme importance and 
challenges of such correlation studies. 
7. Ongoing commercialization and future opportunities 
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Current ongoing commercialization efforts focus not only on improving microneedle-based 
minimally invasive wearable ISF glucose sensors, but also on pioneering wearable sweat sensor-
based dehydration monitoring systems for fitness, military, and industrial workforce applications. 
With a vast market and a set of well validated biomarkers (sweat electrolytes) at hand, 
companies such as General Electric Global Research have been working on a wearable sweat 
sensor for several years for the electrochemical detection of sweat sodium and potassium levels 
(Alizadeh et al., 2018). In 2018, their first generation sweat sensors underwent a valuable field 
test at the U.S. Air Force Academy bootcamp, and the device design has since been honed 
(Kloberdanz, 2019). Epicore Biosystems is a startup, commercializing the Gatorade Gx Sweat 
Patch, which roots from the epidermal microfluidic colorimetric sweat sensor technology 
developed at Northwestern University. Other key players developing sweat sensors for 
dehydration monitoring include: Nix Biosensors, a Harvard Launch Lab-based company, and 
Kenzen, a startup with Headquarters in New York. Large corporations, such as Google, are also 
showing growing interest in wearable sensing devices, displayed by their recent efforts in 
acquiring Fitbit. Further clinical validation of various sweat biomarkers and advances in sensor 
technologies are on the way to propel the commercialization of wearable sweat sensors into the 
domains of disease monitoring, diagnostics and prognostics. The sweat sensor research at the 
University of Cincinnati, for example, has led to the founding of Eccrine Systems that focuses on 
the development of aptamer-based electrochemical sweat sensing technologies for therapeutic 
drug monitoring (Arroyo-Currás et al., 2020). 
In the future, wearable electrochemical sensors are in line to play a critical role in disease 
management. Firstly, therapeutic drug monitoring (TDM) is a clinical practice by which drug 
dosage regimens are optimized through the periodic sampling of plasma or serum drug levels. 
While tedious, conventional TDM is crucial for safely administering drugs that have a narrow 
therapeutic range or highly intervariable pharmacokinetics, such as lithium, L-Dopa, and 
phenytoin. Drug concentrations in sweat and ISF often correlate well with that of plasma or 
serum, and there is a major opportunity in applying wearable electrochemical sensors to make 
TDM cheaper, less invasive, and more accessible (Kovacs et al., 1998; Tai et al., 2018; 
Teymourian et al., 2020c). As an example, a wearable electrochemical microneedle sensor has 
been developed for the continuous monitoring of L-Dopa toward the effective management of 
Parkinson’s disease (Goud et al., 2019). Next, just as the continuous monitoring of glucose has 
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revolutionized the management of diabetes, continuous monitoring of other major disease 
biomarkers can significantly impact patients suffering from alternate diseases. For instance, 
while gout is not as common as diabetes, it still affects roughly 4% of the US population. 
Clinically, uric acid levels in blood are often used for the management of gout. In a recent study, 
a highly sensitive sweat uric acid assay was developed and tested in human trials, demonstrating 
considerable potential of using wearable sweat sensors for gout management (Yang et al., 2020).  
For wearable sensors to be used in reliable selective detection of molecules in complex biofluids 
with high sensitivity, accuracy, and precision, they need to demonstrate analytical performance 
similar to established laboratory-based analytical methods (Sempionatto et al., 2019b). This can 
be challenging since wearable sensors are constantly exposed to uncontrolled conditions during 
on-body operations, including varying pH, temperature, pressure, ionic strength, humidity, and 
biofouling and foreign body response (in case of transdermal sensors). Additionally, the natural 
variations in the body fluid compositions together with different medication and nutrition habits 
can influence the sensor performance. Gaining further understanding of these changing 
conditions and natural variations will guide efforts for further improving the sensor accuracy. To 
achieve accurate wearable chemical sensors, extensive large-scale human trials need to be 
accomplished to establish strong validations of the sensor response with the gold-standard, 
laboratory-based analytical instruments (Hauke et al., 2018; Yang et al., 2020). Further advances 
in biosensing transduction methods through joint multidisciplinary efforts are expected to exploit 
the full potential of wearable sensors for many applications in our daily lives. 
During the time of the COVID-19 pandemic, access to laboratory based molecular diagnostic 
kits has been lagging behind the enormous demands for widespread population level testing, 
prompting the employment of auxiliary wearable sensor devices that can continuously monitor 
physiological and molecular parameters to predict subtle early symptoms of infection and disease 
progression (Jeong et al., 2020). State of the art wearable physiological sensors can be utilized to 
monitor symptoms such as fever, cough and shortness of breath, while developments in wearable 
electrochemical sensor technologies have the potential to continuously monitor molecular 
markers of virus infection as well as symptoms such as inflammation. Many biomarkers have 
been associated with the relevance of COVID-19 by recent studies. For example, bidirectional 
relationship has been shown between COVID-19 and diabetes in which not only diabetes is 
associated with an increased risk of severe COVID-19, but new-onset diabetes or complication 
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of the preexisting diabetes, e.g. diabetic ketoacidosis and hyperosmolarity, has been observed in 
COVID-19 patients (Chee et al., 2020; Li et al., 2020; Ren et al., 2020). The overreaction of the 
immune system or the so-called cytokine storm, in which the cytokines accumulation results in 
local inflammation or hyperinflammation, has been seen during viral infections such as COVID-
19 (Tang et al., 2020). The levels of lactate dehydrogenase have also been correlated with the 
relevance of COVID-19 cases (Henry et al., 2020). Recent studies suggest that current cutting-
edge wearable biochemical sensors are capable of monitoring metabolic and proteomic profiles 
to help in preventing severe complications caused by the current infectious disease or to in 
monitoring the health of vulnerable populations. For example, to aid COVID-19 patients, the 
sweat patches developed by Epicore Biosystems can be used to monitor electrolyte levels and 
fatigue or to track the cytokines in the sweat (“Smart Patch Gx”, 2020). Although not wearable, a 
recent point-of-care wireless electrochemical platform, named SARS-CoV-2 RapidPlex, 
developed by Gao’s group has shown promise for the low cost and rapid detection of COVID-19 
related biochemical markers in serum and saliva samples (Torrente-Rodríguez et al., 2020b). In a 
pilot study, the multiplexed immunosensors were able to detect nucleocapsid protein, anti-spike 
protein IgG and IgM, and C-reactive protein in serum and saliva samples to categorize patients 
into infectious, vulnerable, and/or immune groups. Development of advanced microfluidics for 
automated sample handling or electrochemical sensors with alternate sensing mechanisms are 
crucial to enable the wearable monitoring of the aforementioned COVID related biomarkers.  
Healthy individuals can also benefit greatly from wearable electrochemical sensors in terms of 
managing their health, wellness and nutrition. Recently, a flexible tattoo epidermal sensor was 
developed to track the dynamic changes in sweat vitamin C levels (Sempionatto et al., 2020). 
Trace levels of vitamins, minerals and amino acids in our fluids can thus be continuously 
analyzed to provide personalized nutrition guidance. Furthermore, non-invasive and continuous 
analysis of stress hormones, such as cortisol, can provide a better understanding of our mental 
state and equip us to better cope with stress before it takes a significant toll on our health. A 
recently developed sweat cortisol sensing platform has shown a strong empirical correlation 
between sweat and serum cortisol concentrations (Torrente-Rodríguez et al., 2020a). Widespread 
public adoption of such wearable molecular-level health monitors can elevate public health 
consciousness towards improved quality of life. 
8. Conclusion, prospects and challenges 
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In this review, we have presented the contributions of North American researchers to the 
development of wearable electrochemical sensors. Many pioneering studies have been developed 
in the USA as a result of active collaborations between academic and industrial entities fueled by 
a steep rise in demands for more advanced healthcare and increasing investment by private and 
government bodies. We have discussed the importance of the first concept of wearable 
biosensors, with the rise and mishap of GlucoWatch, which inspired and challenged other venues 
and researches to improve and modify on-body worn bioelectronics. Thus, innovative wearable 
devices were engineered and became seeds to innumerable startups with the great vision of the 
complete lab on the body. 
Our discussion indicates that the wearable biosensors field is a hot research topic mainly in the 
US coastal universities, with less activity from the US central (mid-Western) region. In addition, 
while researchers from Canada and Mexico are more active in developing wearable physical 
sensors toward detection and monitoring of vital signs (e.g. heart rate, blood pressure, etc.), they 
are less engaged in the development of wearable electrochemical sensors for detecting chemical 
markers.   
We were able to realize that, at least in North America, the main driving force for wearable 
biosensors is still related to glucose monitoring. Continuous glucose monitoring is, as of today, 
lively explored by many successful industrial entities and it has motivated and inspired dynamic 
research in the continuous monitoring of several other analytes, such as drugs or nutrients.  
This review also discussed the platforms and detection principles used for wearable sensors, 
together with their advantages and disadvantages. For example, we presented several 
opportunities and challenges in developing wearable affinity sensors. Nowadays, the washing 
and incubation steps associated with such sensors present major challenges for continuous on-
body operation. An elegant and sophisticated solution to overcome such challenges would be the 
development of wearable fluidic systems with actuator elements capable of storing and 
delivering the necessary mixtures autonomously and reversibly, which demands tremendous 
research efforts for realization.  
The integration of electrochemical systems with wireless electronics is a strong research topic in 
North America. The fast-growing advancement in the field is boosted by main US players 
including Silicon Valley enthusiasts, companies such as Google, Apple, Fitbit and several 
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venture capitalists, along with major engineering efforts in leading US universities, towards the 
development of flexible, stretchable and skin conformal electronic circuits. We will soon witness 
automized soft robots capable of detecting and monitoring biochemical molecules in the 
immediate surroundings and environment. For this future, smart bio-gloves and textiles will play 
vital role on giving mechanical robotic protheses the ability to mimic the human skin. These new 
sensing capabilities must follow the desired features for wearables which comprise the use of the 
appropriate matrix, sampling and methodology for a continuous, non-invasive and 
comprehensive monitoring (Fig. 6). 
We expect that reviewing these exciting and innovative devices developed in North America will 
encourage more researchers, companies and entrepreneurs around the world to join this 
incredible journey toward decoding the biological language of our body, translating every sweat, 
saliva and tear droplet into relevant diagnostic information capable of saving and improving our 
lives. Indeed, researchers from Asia and Europe have already made major contributions to this 
exciting field, which are beyond the scope of this article. Being able to understand the chemical 
signals that our body is transmitting is extremally important, especially in these difficult times 
imposed by the current COVID-19 pandemic. In North America, wearable devices are becoming 
great allies to the prevention and reduction of the disease spreading, especially regarding testing 
and screening of patients (Adans-Dester et al., 2020). The COVID-19 pandemic represents a 
major new driving force that shapes the development of modern wearable medical devices. 
Greater attention is thus currently being directed toward wearables able to monitor temperature, 
heart rate, sleep quality, and blood oxygenation which are features associated with the symptoms 
for the early detection of COVID-19. These capabilities will soon be combined with wearable 
chemical sensors to enable patients and medical personnel to be aware of the symptoms on its 
early stages. The importance of wearables during such pandemic episodes goes further than 
helping in the prevention and monitoring of COVID-19 patients. During these difficult times, 
wearables are lifeboats for chronic diseases patients who need regular medical care and would 
otherwise be exposed to contamination or risks by visiting the hospital. Telemedicine coupled 
with wearables is extremely valuable for decreasing the number of physical visits while keeping 
close medical monitoring. Self-monitoring is the key for health, telemedicine, prevention, and 
wellness, and wearable electrochemical sensors are the key keepers in these directions. 
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Figure 1.  Research activity of wearable electrochemical biosensors in North American 
universities over the past decade. 
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Figure 2. Evolution timeline of wearable chemical sensors in North America. a, First 
commercial CGM devices including GlucoWatch (Tierney et al., 2000) and b, Medtronic’s 
Minimed (Gross et al., 2000). c, First textile-based wearable sensor realized through screen 
printing on the elastic waist of underwear (Yang et al., 2010). d, First report on a contact lens 
with embedded sensor for potential application in tear glucose monitoring (Yao et al., 2011). e, 
Use of microneedle arrays toward minimally invasive detection of biomarkers on the tip of 
microneedles (Windmiller et al., 2011). f, First salivary sensor on tooth enamel for bacteria 
detection (Mannoor et al., 2012). g, h, Epidermal sensors based on transfer tattoos (Bandodkar et 
al., 2013a; Windmiller et al., 2012). i, Wearable mouthguard biosensor for amperometric lactate 
biosensing in human saliva samples (Valdés-Ramírez et al., 2014a). j, First integrated wearable 
sensors using wireless transmission based on radio frequency identification (RFID) (Rose et al., 
2015). k, First example of fully integrated, multiplexed wearable sensor for metabolites and 
electrolytes detection in sweat (Gao et al., 2016a). l, Iontophoretic-based sweat stimulation to 
sample the biofluid under sedentary condition (Emaminejad et al., 2017). m, Wearable sensors 
for defense and safety including ring and n, glove-based sensors for detecting vapor explosives 
and nerve-agents (Mishra et al., 2017; Sempionatto et al., 2017a). o, Stimulated sweat collection 
using ‘hex-wick’ material to reduce the required sweat sampling volume (Hauke et al., 2018). p, 
Epidermal BFC-powered sweat biosensor integrated with colorimetric sensors (Nyein et al., 
2019). q, Mass fabrication of microfluidic sensing patches via roll-to-roll processes for 
reproducible sweat analysis (Bandodkar et al., 2019). r, Laser-engraved graphene-based wearable 
sweat sensors for detection of low analytes concentration (Yang et al., 2020). s, Freestanding 
sensor system-enabled smartwatch featuring sweat sampling, electrochemical sensing, and data 
display/transmission in sedentary and high-intensity exercise settings (Zhao et al., 2020). t, Fully 
sweat-powered integrated electronic skin toward multiplexed metabolic sensing (Yu et al., 
2020a).  
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Figure 3. Wearable sensors and platforms. Epidermal sensors are fabricated by patterning 
electrodes on a flexible and/or stretchable substrate. a, An electrochemical tattoo biosensor for 
real-time and noninvasive lactate monitoring in sweat (Jia et al., 2013). b, Textile-based 
electrochemical armband for energy harvesting and storage (Lv et al., 2018). c, Laser-engraved 
graphene epidermal sensors for monitoring uric acid and tyrosine in sweat (Yang et al., 2020). d, 
Omniphobic paper-based smart bandages for monitoring uric acid and pH levels in open wounds. 
Wearable sweat platforms integrate epidermal sensors into a device that acquires, processes, and 
transmits the electrochemical sweat sensor data to a user interface (Pal et al., 2018). e, A battery 
powered smart wristband for the multiplexed analysis of glucose, lactate, sodium and potassium 
in sweat (Gao et al., 2016a). f, A biofuel cell powered battery-free electronic skin for the 
multiplexed analysis of sweat biomarkers such as urea, ammonia, glucose and pH (Yu et al., 
2020a). g, Battery-free RFID sensor bandage for monitoring sweat sodium (Rose et al., 2014). h, 
Battery-free hybrid NFC sensor patch for the simultaneous colorimetric analysis pH and 
chloride, and electrochemical analysis of glucose and lactate (Bandodkar et al., 2019). Tear 
Platforms. Wearable platforms used for tear monitoring. i, Google’s soft contact lens for 
monitoring glucose in tears with embedded electronics and antenna. j, Flexible rolled thick‐film 
flow‐cell for glucose detection in the lachrymal channel (Kagie et al., 2008). k, Eyeglasses 
mounted super hydrophilic microchannel for tear collection and analysis (Sempionatto et al., 
2019). Saliva Platforms. Salivary wearable sensors are developed for continuous saliva 
monitoring. l, mouth guard saliva platform integrated with screen printed sensor and electronic 
circuit for monitoring lactate levels during exercise (Kim et al., 2015b). m, Pacifier biosensor 
platform containing microchannel modified nipple for saliva collection and detection outside of 
the mouth in the integrated detection chamber (García-Carmona et al., 2019). Accessories. 
Commonly used accessories with added sensing capabilities. n, Ring sensor platform with 
integrated detector exposed on the cap and embedded miniaturized electronics for monitoring 
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dangerous vapors such as explosives and nerve agents. ISF platforms, Wearable devices 
developed to monitor ISF biomarkers in situ (Sempionatto et al., 2017a). o, Hollow microneedles 
filled with enzyme rich carbon paste for monitoring tyrosinase toward cancer skin screening 
(Valdés-Ramírez et al., 2014c).  
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Figure 4. Chemical approaches for wearable electrochemical sensor detection of analytes. a, 
Amperometric sensors using oxidase enzymes and mediators for electron shuttle. The 
characteristic signal is the chronoamperogram generated by monitoring the electrical current 
while applying constant potential. Examples of amperometric sensor include the wearable tattoo 
for the simultaneous monitoring of sweat alcohol and ISF glucose (I) (Kim et al., 2018b) and the 
freestanding sensor system-enabled smartwatch for monitoring sweat lactate and glucose during 
exercising (II) (Zhao et al., 2020). b, Voltammetric sensors based on the detection of 
electroactive molecular groups; square wave voltammetry (shown on the right) is one of the 
common techniques used. Examples of voltammetric sensors include the methylxanthine drug 
monitoring sweat patch (I) (Tai et al., 2018) and the fentanyl detecting gloves (II) (Barfidokht et 
al., 2019). c, Potentiometric sensors based on the ion selective electrodes (ISE). A selective 
membrane is used for specific ion recognition, leading to a potential difference across the 
membrane and to a potential signal between the ISE and the reference electrode. Examples of 
wearable potentiometric sensors include the platform for noninvasive simultaneous monitoring 
of Ca2+ and pH (I) (Nyein et al., 2016) and the integrated sudomotor axon reflex sweat 
stimulation for continuous sodium monitoring (II) (Sonner et al., 2017). d, Energy Harvester 
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Sensors based on the use of biofuel cells. Enzymatic fuel oxidation takes place in the anode 
electrode generating electrons to the cathode for the enzymatic reduction reaction of oxygen. The 
electron flux can be used to power electronic devices or as an indicator of the fuel concentration 
for self-powered sensors. Examples of self-powered sensors include the sweat lactate BFC based 
on flexible buck paper (I) (Chen et al., 2019) and the epidermal BFC-powered lactate sweat 
biosensor integrated with colorimetric sensors (II) (Bandodkar et al., 2019). e, Affinity sensor 
based on the use of antibody receptor and enzyme tag for electrochemical detection. Example of 
electrochemical immunosensor sensor include the sweat cortisol detection patch (I) (Torrente-
Rodríguez et al., 2020a). f, Affinity sensor based on the use of molecular imprinting polymer, 
where the analyte is polymerized with the conductive polymer creating the recognition sites. 
Example include the wearable organic electrochemical device for noninvasive sweat cortisol 
sensing (I) (Parlak et al., 2018). g, Affinity sensor based on the use of aptamers, a synthetic 
molecule capable of changing shape and fold in the presence of the target molecule; example 
include the wearable sweat patch for the measurement of cytokine biomarkers (i) (Hao et al., 
2018).  
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Figure 5. Methods for sampling biofluids. Sweat can be stimulated physically (heat) or 
chemically (iontophoresis), then efficiently collected by micro/nanofluidic systems. a, (top) 
Schematic illustrating iontophoretic drug delivery and (bottom) an integrated wristband for 
iontophoretic sweat extraction and electrochemical monitoring of cystic fibrosis and glucose in 
sweat (Emaminejad et al., 2017). b, An epidermal microfluidic microchip device for enhanced 
sweat sampling and electrochemical detection of sweat glucose and lactate (Martín et al., 2017). 
c, Skin-mounted microfluidic networks with capillary bursting valves that guide the flow of 
sweat for time dependent colorimetric detection of sweat lactate, sodium and potassium (Choi et 
al., 2017). d, (top) Schematic depicting nanoliter regime sweat sampling via open nanofluidic 
films (hex-wick) (Twine et al., 2018), and (bottom) its implementation in an integrated 
iontophoretic sweat stimulation and sweat ethanol biosensing patch (Hauke et al., 2018). ISF can 
also be extracted chemically (reverse-iontophoresis) and physically (microneedles). e, (top) 
Schematic showing the operation mechanism for the reverse-iontophoretic extraction of ISF and 
subsequent analysis of ISF glucose, and (bottom) its implementation as a tattoo-based 
electrochemical system (Bandodkar et al., 2015). f, (top) Diagrams of hollow, porous and 
hydrogel microneedles for the minimally invasive extraction of ISF (Liu et al., 2020). (bottom) 
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The left shows two stainless steel microneedles for puncturing skin micropores, and the right 
shows ISF extracted from skin micropores via suction (Samant and Prausnitz, 2018). 
 
Figure 6. Desirable features for future wearable sensing platforms. 
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• History of the research and commercialization efforts of wearable electrochemical sensors in 
North America is overviewed. 
• The wearable platforms used to analyze body fluids such as ISF, sweat, saliva and tear are 
reviewed.  
• Various electrochemical sensing and fluid extraction mechanisms are reviewed and discussed. 
• The prospective on future wearable electrochemical sensors in remote and personalized 
telemedicine is provided. 
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